Company Filing History:
Years Active: 2022
Title: Innovations in Biopharmaceuticals: The Contributions of Inventor Qi Xue
Introduction: Qi Xue is a notable inventor based in Hong Kong, China, who has made significant advancements in the field of biopharmaceuticals. With a total of two patents, Qi's work focuses on the development of recombinant human-basic fibroblast growth factor (rh-bFGF) and its pharmaceutical applications.
Latest Patents: Qi Xue's latest patents include two pivotal inventions. The first patent involves a mutated nucleic acid molecule of recombinant human-basic fibroblast growth factor (rh-bFGF) along with a pharmaceutical composition comprising rh-bFGF and its usages. The second patent details a method for producing soluble recombinant human-basic fibroblast growth factor (rh-bFGF), which encompasses the recombinant factor obtained through the described method, as well as a mutated nucleic acid molecule encoding it.
Career Highlights: Qi Xue is currently employed at Zhuhai Essex Bio-pharmaceutical Co., Ltd., where he has been instrumental in pioneering research and development in biopharmaceuticals. His expertise and innovative approach in the field have earned him recognition among his peers.
Collaborations: Qi has collaborated with notable coworkers, including Haizhou Fang and Peimin Dai, demonstrating a commitment to teamwork and the advancement of scientific knowledge in his industry.
Conclusion: As an inventor, Qi Xue continues to contribute to the biopharmaceutical field through his patents and collaboration with other experts. His work plays a crucial role in the ongoing research and development of effective pharmaceutical treatments that leverage the power of recombinant technology.